CervoMed Inc. (CRVO) Balance Sheet

NASDAQ: CRVOAssets, liabilities, debt and equity over 10 years.

CRVO balance sheet, 2025

December 31, 2025 · U.S. dollars

$23.4M assets = $5.2M liabilities + $18.2M equity

What it owns$23.4MCash & ST investments: $20.9M (89.2%)Cash & ST investments$20.9M · 89%Receivables: $426,993 (1.8%)Other current: $1.3M (5.4%)Other non-current: $841,047 (3.6%)=How it is financed$23.4MCurrent liabilities: $4.7M (19.9%)Current liabilities$4.7M · 20%Other LT liabilities: $520,465 (2.2%)Shareholders’ equity: $18.2M (77.9%)Shareholders’ equity$18.2M · 78%

Both columns are drawn to the same scale: what CRVO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

CRVO financial health

Current ratio4.84
Comfortable · current assets cover current liabilities 4.84×
Equity / assets77.9%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

CRVO balance sheet trends, 2016–2025

CervoMed Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$17.5M2016$23.4M2025+3.3%/yr
Total liabilities$8.3M2016$5.2M2025−5.1%/yr
Shareholders’ equity$9.2M2016$18.2M2025+7.9%/yr
Cash & short-term investments$1.6M2016$20.9M2025+33.5%/yr
Total debt$2.4M2016$12.4M2022+31.2%/yr
Net cash (debt)−$877,1482016−$8.3M2022−$7.4M
Working capital−$2.8M2016$17.9M2025+$20.7M
Book value per share$4.862024$2.022025−58.5%/yr
Current ratio0.3620164.842025+4.48
Debt / equity0.2620160.292021+0.02
Shares outstanding8.1M20249.0M2025+12.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

CRVO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

CRVO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

CRVO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

CRVO balance sheet

CervoMed Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$20.9M$38.9M$7.8M$4.1M$37.3M$18.5M$14.2M$8.0M$8.9M$1.6M
Cash & equivalents$8.2M$9.0M$7.8M$4.1M$37.3M$18.5M$14.2M$8.0M$8.9M$1.6M
Short-term investments$12.6M$29.9M$0$12.4M$0—————
Receivables$426,993$2.3M$915,404$0$69,581$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0
Other current assets$1.3M$1.9M$1.3M$64,127$440,434$260,825$472,464$923,059$769,946$50,844
Total current assets$22.6M$43.1M$10.0M$4.2M$37.8M$18.8M$14.6M$8.9M$9.7M$1.6M
Property, plant & equipment (net)$0$0$0$0$0$298,360$499,409$350,281$460,652$79,755
Goodwill & intangible assets$0$0$0$0$0$8.6M$8.6M$8.6M$15.6M$15.6M
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$841,047$0$7,770$0$15,578$15,771$490,294$298,480$450,491$232,675
Total assets$23.4M$43.1M$10.0M$4.2M$37.8M$27.7M$24.3M$18.2M$26.1M$17.5M
Liabilities
Accounts payable$1.5M$1.5M$662,471$97,302$947,495$545,844$1.3M$198,818$511,956$1.7M
Short-term debt———$12.4M$4.1M$113,469$111,477—$550,000$1.9M
Deferred revenue———−$12.4M−$4.1M———$1.1M—
Total current liabilities$4.7M$3.9M$2.6M$13.2M$2.9M$2.4M$1.7M$804,044$2.7M$4.4M
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations————$0$149,162$247,043———
Other long-term liabilities$520,465$2.4M$1.9M$36.7M$5.9M$479,586$2.4M$1.8M$2.2M$3.9M
Total liabilities$5.2M$3.9M$2.6M$13.2M$2.9M$2.9M$4.1M$2.6M$4.9M$8.3M
Shareholders' equity
Common stock & paid-in capital$9,252$8,702$5,674$518$2,038$64,016$33,481$3,377$968$10,346
Retained earnings (deficit)−$97.7M−$70.7M−$54.4M−$52.3M−$130.0M−$105.9M−$91.7M−$79.9M−$61.6M−$60.2M
Accumulated other comprehensive income$5,816$56,197−$10.0M−$35,375−$24.3M—————
Total shareholders' equity$18.2M$39.2M$7.4M−$9.0M$34.9M$24.8M$20.1M$15.6M$21.2M$9.2M
Key figures
Total debt———$12.4M$10.0M$149,162$247,043—$550,000$2.4M
Net cash (debt)———−$8.3M$27.3M$18.4M$13.9M—$8.3M−$877,148
Working capital$17.9M$39.2M$7.4M−$9.0M$34.9M$16.3M$12.9M$8.1M$7.0M−$2.8M
Tangible book value$18.2M$39.2M$7.4M−$9.0M$34.9M$16.2M$11.5M$7.0M$5.7M−$6.4M
Book value per share$2.02$4.86————————
Shares outstanding9.0M8.1M————————
Current ratio4.8411.113.840.3212.927.718.5111.093.590.36
Quick ratio4.5710.613.350.3112.777.608.249.943.310.35
Debt / equity————0.290.010.01—0.030.26
Equity / assets77.9%91.0%74.0%−216.4%92.3%89.5%82.9%85.8%81.2%52.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 13, 2026); data from EODHD.

CRVO financial position

At the end of fiscal 2025 (December 31, 2025), CervoMed had total assets of $23.4 million (down 45.7% from a year earlier), total liabilities of $5.2 million and shareholders' equity of $18.2 million. Its current ratio was 4.84. In the latest quarter (ended June 30, 2026) total assets were $26.0 million and equity $23.0 million.

Related: CRVO income statement, CRVO cash flow statement, CRVO key metrics. See the CRVO stock overview for the latest quote and news.

CRVO balance sheet FAQ

What are CervoMed's total assets?

CervoMed reported total assets of $23.4 million at the end of fiscal 2025 (December 31, 2025), compared with $43.1 million a year earlier.

How much cash does CervoMed have?

CervoMed held $20.9 million in cash and short-term investments at the end of fiscal 2025.

What is CervoMed's book value?

CervoMed's shareholders' equity (book value) was $18.2 million at the end of fiscal 2025, or $2.02 per share.

What is CervoMed's current ratio?

CervoMed had current assets of $22.6 million and current liabilities of $4.7 million, a current ratio of 4.84 (it can cover its short-term obligations).

Biotechnology: balance sheet